Lonnie Moulder
Chairman at DIANTHUS THERAPEUTICS, INC.
Net worth: 44 M $ as of 2024-03-30
Profile
Mr. Leon O.
Moulder is a Chairman at Dianthus Therapeutics, Inc., a Managing Member at Tellus BioVentures LLC, an Independent Director at Zai Lab Ltd., a Chairman at Dianthus Therapeutics OpCo, Inc., a Chairman at Temple University Japan, a Chief Executive Officer at Zenas Pharma, Inc. and a Member at The University of Chicago Booth School of Business.
He is on the Board of Directors at Helsinn Healthcare SA, Zai Lab Ltd., Aegle Therapeutics Corp., Helsinn SA, Interius BioTherapeutics, Inc., Navrogen, Inc., Praeventix, Inc., TamuroBio, Inc., The Fox Chase Cancer Center, viTToria Biotherapeutics, Inc. and Temple University (Pennsylvania).
Mr. Moulder was previously employed as a Chairman by Trevena, Inc., a Chief Executive Officer & Director by Tesaro, Inc., a Vice Chairman, President & Chief Executive Officer by Abraxis BioScience, Inc., a Vice Chairman by Eisai Corp.
of North America, a President & Chief Executive Officer by MGI PHARMA Biologics, Inc., a President, Chief Executive Officer & Director by MGI PHARMA, Inc., a VP-Business Development & Commercial Affairs by COULTER CELLULAR THERAPIES INC, a Director-Oncology & Anti Infective Products Group by Hoechst Marion Roussel, Inc., a Principal by Marion Laboratories, a Principal by Marion Merrell Dow Pharmaceutical, Inc., and a Clinical Pharmacist by Temple University Hospital, Inc. He also served on the board at Cubist Pharmaceuticals, Inc., Biotechnology Innovation Organization and Mirati Therapeutics, Inc. He received his undergraduate degree from Temple University (Pennsylvania) and an MBA from The University of Chicago Booth School of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-01-21 | 1,436,745 ( 4.90% ) | 43 M $ | 2024-03-30 | |
ZAI LAB LTD.
0.04% | 2023-06-29 | 405,180 ( 0.04% ) | 667 842 $ | 2024-03-30 |
TREVENA, INC.
0.03% | 2023-06-14 | 6,000 ( 0.03% ) | 2 760 $ | 2024-03-30 |
Lonnie Moulder active positions
Companies | Position | Start |
---|---|---|
ZAI LAB LIMITED | Director/Board Member | 2018-12-31 |
DIANTHUS THERAPEUTICS, INC. | Chairman | 2023-09-10 |
Praeventix, Inc.
Praeventix, Inc. BiotechnologyHealth Technology Praeventix, Inc. is a biotechnology company founded by Dr. Douglas Pippin based on discoveries researched by Dr. Pippin and at Temple University. The company is based in Exton, PA, and was founded by Douglas Pippin. The company is initially focused on the development of pre-clinical candidate pra-523, a potential first-in-class neuromodulatory therapy for pruritus and other potential indications, including IBD. Praeventix is pursuing novel serotonergic therapeutics for inflammatory bowel disease (IBD) and cocaine use disorder (CUD). Douglas Pippin has been the CEO since incorporation. | Director/Board Member | - |
Navrogen, Inc.
Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Helsinn SA | Director/Board Member | - |
ViTToria Biotherapeutics, Inc.
ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Director/Board Member | - |
The University of Chicago Booth School of Business | Corporate Officer/Principal | - |
Temple University Japan | Chairman | - |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Chairman | - |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Lonnie Moulder
Companies | Position | End |
---|---|---|
░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░ ░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Lonnie Moulder
Temple University (Pennsylvania) | Undergraduate Degree |
The University of Chicago Booth School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
TREVENA, INC. | Health Technology |
ZAI LAB LIMITED | Health Technology |
Private companies | 26 |
---|---|
MGI PHARMA, Inc.
MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Eligix, Inc.
Eligix, Inc. Medical/Nursing ServicesHealth Services Eligix, Inc. develops and distributes medicines. It also offers cellular transplantation and immune therapies to enhance human immune response to cancers and infectious diseases. The company is located in Medford, MA | Health Services |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
The Fox Chase Cancer Center
The Fox Chase Cancer Center Hospital/Nursing ManagementHealth Services The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA. | Health Services |
Eisai Corp. of North America
Eisai Corp. of North America Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Corp. of North America is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Woodcliff Lake, NJ. | Health Technology |
MGI PHARMA Biologics, Inc.
MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Health Technology |
Marion Laboratories | Distribution Services |
Hoechst Marion Roussel, Inc. | |
Marion Merrell Dow Pharmaceutical, Inc. | |
Temple University Hospital, Inc.
Temple University Hospital, Inc. Hospital/Nursing ManagementHealth Services Temple University Hospital, Inc. owns and operates a healthcare centre. The company provides pulmonology, cardiology, gastroenterology, hematology, nephrology, oncology, neurology, ophthalmology, otorhinolaryngology, and bone marrow transplantation services. Additionally, it offers heart, lung, kidney, and trauma surgery; maxillofacial surgery; psychiatry; radiation oncology; and diagnostic imaging services. The company also provides treatment of infectious diseases and diabetes. The company was founded in 1992 and is headquartered in Philadelphia, PA. | Health Services |
Navrogen, Inc.
Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Dianthus Therapeutics, Inc. (Massachusetts)
Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Health Technology |
Aegle Therapeutics Corp.
Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Health Technology |
TamuroBio, Inc.
TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Tamurobio, Inc. provides biotechnology services. The company was founded in 2019 and is headquartered in Wayne, PA. | Commercial Services |
Tellus Bioventures LLC
Tellus Bioventures LLC Investment ManagersFinance Tellus BioVentures LLC (Tellus BioVentures) is a venture capital firm founded in 2019 by Leon O. Moulder. The firm is headquartered in Miromar Lakes, Florida. | Finance |
Interius BioTherapeutics, Inc.
Interius BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Interius BioTherapeutics, Inc. is a biopharmaceutical company that targets cancer. The company was founded by Saar Gill and is headquartered in Philadelphia, PA. | Health Technology |
ViTToria Biotherapeutics, Inc.
ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Health Technology |
Helsinn SA | |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Health Technology |
Praeventix, Inc.
Praeventix, Inc. BiotechnologyHealth Technology Praeventix, Inc. is a biotechnology company founded by Dr. Douglas Pippin based on discoveries researched by Dr. Pippin and at Temple University. The company is based in Exton, PA, and was founded by Douglas Pippin. The company is initially focused on the development of pre-clinical candidate pra-523, a potential first-in-class neuromodulatory therapy for pruritus and other potential indications, including IBD. Praeventix is pursuing novel serotonergic therapeutics for inflammatory bowel disease (IBD) and cocaine use disorder (CUD). Douglas Pippin has been the CEO since incorporation. | Health Technology |
Dianthus Therapeutics, Inc. |
- Stock Market
- Insiders
- Lonnie Moulder